To analyze the impact of CD8+ T cell exhaustion on immunotherapy response, we then calculated the exhaustion score of 15 patients with lung adenocarcinoma for whom tumors were analyzed by RNA-seq at baseline and on-treatment. This evidence concerns the gene CD8A and lung adenocarcinoma.